WO2007011162A1 - Synthetic method of optically pure (s)-3-hydroxypyrrolidine - Google Patents
Synthetic method of optically pure (s)-3-hydroxypyrrolidine Download PDFInfo
- Publication number
- WO2007011162A1 WO2007011162A1 PCT/KR2006/002835 KR2006002835W WO2007011162A1 WO 2007011162 A1 WO2007011162 A1 WO 2007011162A1 KR 2006002835 W KR2006002835 W KR 2006002835W WO 2007011162 A1 WO2007011162 A1 WO 2007011162A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- acid
- hydroxypyrrolidine
- compound
- optically pure
- Prior art date
Links
- JHHZLHWJQPUNKB-BYPYZUCNSA-N (3s)-pyrrolidin-3-ol Chemical compound O[C@H]1CCNC1 JHHZLHWJQPUNKB-BYPYZUCNSA-N 0.000 title claims abstract description 53
- 238000010189 synthetic method Methods 0.000 title description 6
- 238000000034 method Methods 0.000 claims abstract description 49
- -1 amine salt Chemical class 0.000 claims abstract description 47
- 239000002253 acid Substances 0.000 claims abstract description 41
- 150000003138 primary alcohols Chemical class 0.000 claims abstract description 27
- 125000006242 amine protecting group Chemical group 0.000 claims abstract description 25
- 125000002843 carboxylic acid group Chemical group 0.000 claims abstract description 21
- 239000007858 starting material Substances 0.000 claims abstract description 20
- 238000007363 ring formation reaction Methods 0.000 claims abstract description 16
- 230000002140 halogenating effect Effects 0.000 claims abstract description 13
- 150000001412 amines Chemical class 0.000 claims abstract description 10
- 150000003951 lactams Chemical class 0.000 claims abstract description 6
- 238000006243 chemical reaction Methods 0.000 claims description 39
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 29
- 150000001875 compounds Chemical class 0.000 claims description 25
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 24
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 24
- 239000000203 mixture Substances 0.000 claims description 15
- 125000000217 alkyl group Chemical group 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- 239000007810 chemical reaction solvent Substances 0.000 claims description 13
- 229910052736 halogen Inorganic materials 0.000 claims description 12
- SXDBWCPKPHAZSM-UHFFFAOYSA-N bromic acid Chemical compound OBr(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-N 0.000 claims description 11
- 230000002194 synthesizing effect Effects 0.000 claims description 11
- 230000004913 activation Effects 0.000 claims description 10
- 150000001408 amides Chemical class 0.000 claims description 10
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 9
- 239000012279 sodium borohydride Substances 0.000 claims description 8
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 8
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 6
- 125000003277 amino group Chemical group 0.000 claims description 6
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 4
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 4
- 239000003638 chemical reducing agent Substances 0.000 claims description 4
- 125000004185 ester group Chemical group 0.000 claims description 4
- FXXACINHVKSMDR-UHFFFAOYSA-N acetyl bromide Chemical compound CC(Br)=O FXXACINHVKSMDR-UHFFFAOYSA-N 0.000 claims description 3
- 239000011575 calcium Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 2
- 150000003509 tertiary alcohols Chemical class 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims 4
- 238000000746 purification Methods 0.000 abstract description 10
- 238000004821 distillation Methods 0.000 abstract description 4
- 239000011541 reaction mixture Substances 0.000 description 19
- 238000002360 preparation method Methods 0.000 description 17
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000002994 raw material Substances 0.000 description 11
- 238000005160 1H NMR spectroscopy Methods 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 150000002367 halogens Chemical group 0.000 description 8
- 238000010992 reflux Methods 0.000 description 8
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 6
- 239000000825 pharmaceutical preparation Substances 0.000 description 6
- 229940127557 pharmaceutical product Drugs 0.000 description 6
- FRKGSNOMLIYPSH-VKHMYHEASA-N (3s)-3-hydroxypyrrolidin-2-one Chemical compound O[C@H]1CCNC1=O FRKGSNOMLIYPSH-VKHMYHEASA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 229940126214 compound 3 Drugs 0.000 description 5
- 229940125898 compound 5 Drugs 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 230000032050 esterification Effects 0.000 description 4
- 238000005886 esterification reaction Methods 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- ARXKVVRQIIOZGF-UHFFFAOYSA-N 1,2,4-butanetriol Chemical compound OCCC(O)CO ARXKVVRQIIOZGF-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LPIMZWPKLBGWRN-BYPYZUCNSA-N [(2s)-4-amino-1-bromobutan-2-yl] bromate Chemical compound NCC[C@@H](CBr)OBr(=O)=O LPIMZWPKLBGWRN-BYPYZUCNSA-N 0.000 description 3
- SXDBWCPKPHAZSM-UHFFFAOYSA-M bromate Inorganic materials [O-]Br(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-M 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 125000004494 ethyl ester group Chemical group 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000001577 simple distillation Methods 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- JHHZLHWJQPUNKB-SCSAIBSYSA-N (3r)-pyrrolidin-3-ol Chemical compound O[C@@H]1CCNC1 JHHZLHWJQPUNKB-SCSAIBSYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UWTATZPHSA-N (R)-malic acid Chemical compound OC(=O)[C@H](O)CC(O)=O BJEPYKJPYRNKOW-UWTATZPHSA-N 0.000 description 2
- BSIMZHVOQZIAOY-SCSAIBSYSA-N 1-carbapenem-3-carboxylic acid Chemical compound OC(=O)C1=CC[C@@H]2CC(=O)N12 BSIMZHVOQZIAOY-SCSAIBSYSA-N 0.000 description 2
- AVSUMWIDHQEMPD-UHFFFAOYSA-N 2-(oxiran-2-yl)ethanol Chemical compound OCCC1CO1 AVSUMWIDHQEMPD-UHFFFAOYSA-N 0.000 description 2
- 229940127291 Calcium channel antagonist Drugs 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- 0 NCC*[C@](C(O)O)O Chemical compound NCC*[C@](C(O)O)O 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 229940035676 analgesics Drugs 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- VXMOONUMYLCFJD-DHLKQENFSA-N barnidipine Chemical compound C1([C@@H]2C(=C(C)NC(C)=C2C(=O)OC)C(=O)O[C@@H]2CN(CC=3C=CC=CC=3)CC2)=CC=CC([N+]([O-])=O)=C1 VXMOONUMYLCFJD-DHLKQENFSA-N 0.000 description 2
- 229960002992 barnidipine Drugs 0.000 description 2
- 235000019445 benzyl alcohol Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000480 calcium channel blocker Substances 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 229940125782 compound 2 Drugs 0.000 description 2
- ZTPZDOKWCPQOEY-LURJTMIESA-N ethyl n-[(3s)-3,4-dihydroxybutyl]carbamate Chemical compound CCOC(=O)NCC[C@H](O)CO ZTPZDOKWCPQOEY-LURJTMIESA-N 0.000 description 2
- 230000026030 halogenation Effects 0.000 description 2
- 238000005658 halogenation reaction Methods 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- MTJGVAJYTOXFJH-UHFFFAOYSA-N 3-aminonaphthalene-1,5-disulfonic acid Chemical compound C1=CC=C(S(O)(=O)=O)C2=CC(N)=CC(S(O)(=O)=O)=C21 MTJGVAJYTOXFJH-UHFFFAOYSA-N 0.000 description 1
- ARZSRJNMSIMAKS-UHFFFAOYSA-N 4-aminobutane-1,2-diol Chemical compound NCCC(O)CO ARZSRJNMSIMAKS-UHFFFAOYSA-N 0.000 description 1
- AMKGKYQBASDDJB-UHFFFAOYSA-N 9$l^{2}-borabicyclo[3.3.1]nonane Chemical compound C1CCC2CCCC1[B]2 AMKGKYQBASDDJB-UHFFFAOYSA-N 0.000 description 1
- FEJUGLKDZJDVFY-UHFFFAOYSA-N 9-borabicyclo[3.3.1]nonane Substances C1CCC2CCCC1B2 FEJUGLKDZJDVFY-UHFFFAOYSA-N 0.000 description 1
- XAZKFISIRYLAEE-PKPIPKONSA-N C[C@@H]1CC(C)CC1 Chemical compound C[C@@H]1CC(C)CC1 XAZKFISIRYLAEE-PKPIPKONSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 229910010084 LiAlH4 Inorganic materials 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 150000003973 alkyl amines Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000009435 amidation Effects 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 102000048260 kappa Opioid Receptors Human genes 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 239000000018 receptor agonist Substances 0.000 description 1
- 229940044601 receptor agonist Drugs 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 150000003333 secondary alcohols Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 108020001588 κ-opioid receptors Proteins 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Definitions
- the present invention relates to a method of preparing optically pure
- Examples in which (S)-3-hydroxypyrrolidine represented by Formula 1 are actually used in preparing pharmaceutical products are as follows: a major intermediate raw material of a calcium antagonist (Barnidipine) (European Patent Laid-Open Publication No. 160,451; J. Med. Chem. 1986, 29, 2504-2511; Japanese Patent Laid- Open Publication No. (Sho) 61-267577; Japanese Patent Laid-Open Publication No. (Sho) 61-63652); carbapenem antibiotics (Heterocycles, vol 24, No 5, 1986; Tetrahedron Lett., 25, 2793, 1984; International Publication No. WO88/08845; J. Org. Chem.
- the present invention is conceived to solve the aforementioned problems. It is an object of the present invention to provide a method of industrially and economically preparing (S)-3-hydroxypyrrolidine by using inexpensive, optically active 4-amino-(S)-2-hydroxybutylic acid as a starting material, and a method of optically or chemically purifying (S)-3-hydroxypyrrolidine through simple distillation under reduced pressure without an additional purification process.
- a method of preparing (S)-3-hydroxypyrrolidine according to the present invention comprises the steps of: introducing an amine protecting group into an amine group of optically pure 4-amino-(S)-2-hydroxybutylic acid represented by the following Formula 2 used as a starting material; reducing a carboxylic acid group into a primary alcohol; removing the amine protecting group to form an amine salt; halogenating the primary alcohol to perform activation into a leaving group; and synthesizing optically pure (S)-3-hydroxypyrrolidine represented by the following Formula 1 through amine cyclization:
- a compound prepared in the step of forming the amine protecting group in the amine group of 4-amino-(S)-2-hydroxybutylic acid may comprise a compound represented by the following Formula 3:
- R is a C ⁇ C linear or branched alkyl or benzyl group.
- the step of reducing the carboxylic acid group to the primary alcohol may be performed by esterifying the carboxylic acid group into an ester compound represented by the following Formula 4 and reducing an ester group to the primary alcohol:
- a compound prepared in the step of removing the amine protecting group to form the amine salt may comprise a compound represented by the following
- HX is halogen acid or sulfuric acid.
- a compound prepared in the step of halogenating the primary alcohol to perform activation into the leaving group may comprise a compound represented by the following Formula 6: [33] ⁇ Formula 6>
- HX is halogen acid or sulfuric acid
- X is halogen
- 4-amino-(S)-2-hydroxybutylic acid may employ at least one reaction solvent selected from the group consisting of water, 1,4-dioxane, tetrahydrofuran and acetonitrile.
- the step of halogenating the primary alcohol to perform activation into the leaving group may use bromic acid and acetic acid, anhydride bromic acid or acetylbromide when the primary alcohol is brominated.
- the step of halogenating the primary alcohol to perform activation into a leaving group may be performed at a reaction temperature ranging from 0 to 100 0 C by using a C ⁇ C liquid alkyl solvent with a carboxylic acid group as a reaction solvent.
- the step of synthesizing optically pure (S)-3-hydroxypyrrolidine through the amine cyclization may be performed by using water, C ⁇ C linear or branched alcohol, or a mixture thereof as a reaction solvent, and Na CO , K CO , NaHCO , LiOH, NaOH, KOH, Ca(OH) or TEA as a base.
- a method of preparing (S)-3-hydroxypyrrolidine according to the present invention comprises the steps of: forming an ester compound by esterifying a carboxylic acid group of optically pure 4-amino-(S)-2-hydroxybutylic acid represented by the following Formula 2 used as a starting material; forming a lactam compound through lactam cyclization of the ester compound; and synthesizing optically pure (S)-3-hydroxypyrrolidine represented by the following Formula 1 through amide reduction of the lactam compound:
- ester compound may comprise a compound represented by the following Formula 7: [44] ⁇ Formula 7>
- R is a C ⁇ C linear or branched alkyl or benzyl group
- HX is halogen acid or sulfuric acid
- the step of preparing the ester compound by esterifying the carboxylic acid group of optically pure 4-amino-(S)-2-hydroxybutylic acid may employ a base selected from the group consisting of sodium carbonate, potassium carbonate, sodium bicarbonate, potassium hydroxide, sodium hydroxide and a tertiary alcohol.
- the step of synthesizing optically pure (S)-3-hydroxypyrrolidine through the amide reduction of the lactam compound may use diglym as a reaction solvent.
- the step of synthesizing optically pure (S)-3-hydroxypyrrolidine through the amide reduction of the lactam compound may be performed at a reaction temperature of 20 to 15O 0 C by using 1 to 10 equivalents of sodium borohydride as a reducing agent and 1 to 4 equivalents of sulfuric acid based on the lactam compound.
- the present invention provides a method capable of economically and industrially preparing (S)-3-hydroxypyrrolidine by using inexpensive, optically active 4-amino-(S)-2-hydroxybutylic acid as a starting material, and preparing optically and chemically pure (S)-3-hydroxypyrrolidine through simple distillation under reduced pressure without an additional purification process.
- the present invention provides a method of preparing optically and chemically pure (S)-3-hydroxypyrrolidine, which employs a process of the following Reaction Scheme 1 using 4-amino-(S)-2-hydroxybutylic acid as a starting material, or a mild reaction condition of Reaction Scheme 2 (to be described later) and a simple purifica tion process.
- the present invention provides a method of preparing (S)-3-hydroxypyrrolidine, which comprises the steps of: 1) introducing an amine protecting group into a compound 2 to obtain a compound 3; 2) reducing a carboxylic acid group of the compound 3 to a primary alcohol to obtain a compound 5; 3) removing the amine protecting group from the compound 5 to obtain an amine salt 6; 4) halogenating the primary alcohol of the amine salt 6 to obtain a compound 7 having an activated leaving group; and 5) performing amine cyclization of the compound 7 to obtain (S)-3-hydroxypyrrolidine 1.
- the step of introducing an amine protecting group into a compound 2 can be achieved by introducing an amine protecting group through amidation or carbamation conventionally used in the art.
- the amine protecting group can be introduced in the form of amide by using C ⁇ C aliphatic or aromatic alkylcarboxyl halide (or a leaving group such as an ester).
- C ⁇ C aliphatic or aromatic alkylcarboxyl halide or a leaving group such as an ester
- R is preferably a C ⁇ C linear or branched alkyl or benzyl group.
- reaction solvent there is no limitation on a reaction solvent, but it is desirable to select the reaction solvent from the group consisting of water, 1,4-dioxane, tetrahydrofuran, acetonitrile and a mixture thereof.
- the step of preparing a compound 5 by reducing the carboxylic acid group of the compound 3 to a primary alcohol can be performed through a process of directly reducing a carboxylic acid group to a primary alcohol, which is known in the art, without any limitation.
- Reducing agents useful in the step include sodium borohydride (BH3)(JACS, 92, 1637, 1970; JOC 38, 2786, 1973), 9-BBN (JOC, 42, 512, 1977), sodium borohydride under the presence of a catalyst (JACS 78, 2582, 1956; Syn 695, 1980), lithium aluminum hydride (JACS, 109, 7816, 1987), and the like. Since details of the reduction methods can be found in these references, further description thereof will be omitted herein.
- the carboxylic acid group of the compound 3 is subjected to esterification to obtain the following ester compound, and the ester group of the compound 4 is then reduced to obtain the compound 5.
- the esterification may be performed by means of esterification of a carboxylic acid, which is known in the art, without any limitation.
- R be an amine protecting group, and R be a C ⁇ C linear or branched alkyl or benzyl group.
- the reduction of the ester compound 4 may be performed by means of reduction of an ester group into an alcohol, which is known in the art, without any limitation.
- the reduction is carried out by using sodium borohydride as a reducing agent in an amount of 1 to 10 equivalents, more preferably 2 to 5 equivalents.
- the step of preparing the amine salt 6 by removing the amine protecting group from the compound 5 can be achieved by removing the amine protecting group through agitation with or without reflux after addition of an acid such as halogen acid or sulfuric acid thereto.
- an acid such as halogen acid or sulfuric acid thereto.
- the primary alcohol should be selectively halogenated.
- the selective activation of the primary alcohol in the present invention can be achieved by the halogenation.
- halogenating agents generally known in the art can be used, but it is preferable to perform bromination in view of reactivity by using, as a brominating agent, anhydride bromic acid, more preferably acetylbromide and bromic acid/acetic acid.
- an intermediate with an acetylated secondary alcohol is first synthesized, and a target substance with a brominated primary alcohol can be obtained by reacting the intermediate with an alcohol at an elevated temperature.
- a liquid compound having a C ⁇ C alkylcarboxylic acid group as a reaction solvent, more preferably an acetic acid. This is carried out at a reaction temperature ranging from 0 to 100 0 C, preferably 10 to 5O 0 C for 1 to 24 hours, preferably for 3 to 6 hours.
- the step of preparing (S)-3-hydroxypyrrolidine 1 through amine cyclization of the compound 7 uses a reaction solvent selected from the group consisting of water, a C ⁇ C linear or branched alcohol and a mixture thereof, and a base selected from the group consisting of Na CO , K CO , NaHCO , LiOH, NaOH, KOH, Ca(OH) and TEA.
- a reaction solvent selected from the group consisting of water, a C ⁇ C linear or branched alcohol and a mixture thereof
- a base selected from the group consisting of Na CO , K CO , NaHCO , LiOH, NaOH, KOH, Ca(OH) and TEA.
- the amine cyclization may be carried out in succession to the step of preparing the compound 7 with an activated leaving group by halogenating the primary alcohol of the amine salt 6.
- the method of the following Reaction Scheme 2 as another method of the present invention is a method of preparing chemically and optically pure (S)-3-hydroxypyrrolidine under a mild reaction condition and through a simple purification process by using 4-amino-(S)-2-hydroxybutylic acid as a starting material.
- R be a C ⁇ C linear or branched alkyl or benzyl group
- HX be halogen acid, sulfuric acid or fatty acid
- the present invention provides a method of preparing (S)-3-hydroxypyrrolidine 1, which comprises the steps of: 1) esterifying a carboxylic acid group of a starting material 2 to obtain an ester compound 8; 2) forming a lactam compound 9 through lactam cyclization of the ester compound 8; and 3) reducing a carbonyl group of the lactam compound 9 through amide reduction.
- the esterification and lactam cyclization mentioned above may be subjected to a purification process in each of the steps but are preferably performed consecutively without any purification process.
- a C ⁇ C linear or branched alkyl or benzyl alcohol is added to the starting material, an acidic condition is made by adding 1 to 10 equivalents, preferably 1 to 2 equivalents of halogen acid, sulfuric acid or an organic acid, and then, the mixture is reacted at a temperature of 0 to 15O 0 C (or reflux condition) under the acidic condition.
- an acidic condition is made by adding 1 to 10 equivalents, preferably 1 to 2 equivalents of halogen acid, sulfuric acid or an organic acid, and then, the mixture is reacted at a temperature of 0 to 15O 0 C (or reflux condition) under the acidic condition.
- a solvent there is no limitation on a solvent, but it is preferable to employ a C ⁇ C linear or branched alkyl or benzyl alcohol as a solvent.
- the step of forming the lactam compound 9 through lactam cyclization of the ester compound 8 may be subjected to an additional purification process after the step of preparing the ester compound 8 by esterifying the carboxylic acid group of the starting material 2. However, it is more desirable to consecutively perform these steps.
- reaction solvent include, but is not limited to, water, an alcohol and the like, and it is preferable to use the same solvent as used for the preparation of the compound 8.
- the reaction solvent it is preferable to use diglym as the reaction solvent and the reaction is performed by using 1 to 10 equivalents, preferably 2 to 5 equivalents of sodium borohydride and 2 to 4 equivalents of sulfuric acid at a reaction temperature of 20 to 15O 0 C, preferably 70 to 100 0 C.
- the resulting reaction mixture is treated at pH 7 or more, concentrated under reduced pressure to remove the solvent, and then subjected to distillation under reduced pressure, thereby easily obtaining chemically and optically pure (S)-3-hydroxypyrrolidine 1.
- reaction mixture was concentrated under reduced pressure and cooled down to 1O 0 C, and then, its pH was lowered to 1.2 or less by adding concentrated hydrochloric acid.
- the resulting mixture was extracted with ethyl acetate (450D), and the extract thus obtained was dried with anhydrous magnesium sulfate and then filtered and concentrated to obtain 153 g of 4-ethoxycarbonylamino-(S)-2-hydroxybutylic acid 3.
- reaction mixture was added with IOOD of methanol and agitated for 1 hour to inactivate sodium borohydride. Then, pH of the reaction mixture was adjusted to 1.2 or less by adding concentrated hydrochloric acid, and agitated at 5 0 C for 1 hour. The final reaction mixture was filtered under reduced pressure to remove crystals generated during the reaction. A filtrate thus obtained was concentrated under reduced pressure to obtain 89 g of crude 4-ethoxycarbonylamino-(S)- 1 ,2-butandiol 5.
- (S)-3-Hydroxypyrrolidine 1 could be prepared even when performing the reaction by using the same raw materials as Example 6 but adding 100 g of potassium hydroxide as a base. [111]
- the present invention provides a method of economically and industrially preparing (S)-3-hydroxypyrrolidine, and preparing optically and chemically pure (S)-3-hydroxypyrrolidine through simple distillation under reduced pressure without an additional purification process during reaction.
- (S)-3-hydroxypyrrolidine thus prepared can be effectively used as a major raw material for preparation of various chiral pharmaceutical products, such as a major intermediate raw material of a calcium antagonist (Barnidipine), carbapenem antibiotics, quinolone- based antibiotics, analgesics, and a major intermediate raw material of a neurotransmitter, in a very wide industrial field.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
A method of preparing optically pure (S)-3-hydroxypyrrolidine is disclosed. The present invention provides a method of economically and industrially preparing optically and chemically pure (S)-3-hydroxypyrrolidine, through a process comprising introducing an amine protecting group by using optically pure 4-amino-(S)-2-hydroxybutylic acid as a starting material, reducing a carboxylic acid group into a primary alcohol, removing the amine protecting group to form an amine salt, halogenating the primary alcohol, and amine cyclization; and through a simple purification process, i.e., distillation under reduced pressure. As another method, the present invention provides a method of preparing optically and chemically pure (S)-3-hydroxypyrrolidine, through a process comprising esterifying optically pure 4-amino-(S)-2-hydroxybutylic acid as a starting material, lactam cyclization, and reduction.
Description
Description
SYNTHETIC METHOD OF OPTICALLY PURE (S)-3-HYDROXYPYRROLIDINE
Technical Field
[1] The present invention relates to a method of preparing optically pure
(S)-3-hydroxypyrrolidine, and more particularly, to a simple and economical method of preparing optically and chemically pure (S)-3-hydroxypyrrolidine through an economical and industrial process and a simple purification process, i.e., distillation under reduced pressure, by using optically pure 4-amino-(S)-2-hydroxybutylic acid as a starting material. Background Art
[2] (S)-3-hydroxypyrrolidine represented by the following Formula 1 is a very important compound in preparing pharmaceutical products, which has been widely used as a major chiral intermediate for pharmaceutical products commercially available on the market and new pharmaceutical products under clinical tests, and thus, there have been many studies thereon.
[3] <Formula 1>
[4] H
[5] Examples in which (S)-3-hydroxypyrrolidine represented by Formula 1 are actually used in preparing pharmaceutical products are as follows: a major intermediate raw material of a calcium antagonist (Barnidipine) (European Patent Laid-Open Publication No. 160,451; J. Med. Chem. 1986, 29, 2504-2511; Japanese Patent Laid- Open Publication No. (Sho) 61-267577; Japanese Patent Laid-Open Publication No. (Sho) 61-63652); carbapenem antibiotics (Heterocycles, vol 24, No 5, 1986; Tetrahedron Lett., 25, 2793, 1984; International Publication No. WO88/08845; J. Org. Chem. 1992, 57, 4352-4361); quinolone-based antibiotics (U.S. Patent No. 4,916,141; European Patent Laid-Open Publication No. 391,169; European Patent laid-Open Publication No. 304,087), analgesics (κ-receptor agonists) (European Patent Laid- Open Publication Nos. 398,720 and 366,327; J. Med. Chem., 1994, 37, 2138-2144), and a major intermediate raw material of a neurotransmitter (International Publication No. WO01/19817). That is, (S)-3-hydroxypyrrolidine is used as a major substance for preparation of various chiral pharmaceutical products in a wide range of application
fields.
[6] Conventional techniques related to preparation of optically pure
(S)-3-hydroxypyrrolidine, which is useful as a major intermediate for preparation of chiral compounds described above, will be described below.
[7] For example, a method of preparing 3-(R)-hydroxypyrrolidine in a single step reaction involving decarboxylation using (R)-3-hydroxy-L-proline as a starting material is disclosed (JP2001220372; WO97/43256; JP05255204; Synlett, 1995, 55-57; Syn. Comm. 1994, 24, 1381-1387; Korean J. of Med. Chem. 1993, 3, 72-80; Syn. Comm. 1993, 23, 2691-2699; J. Chem. Soc. Perkin Trans. 1. 1993, 1421-1424; Bioorganic & Medicinal Chemistry Letters, 2, 827). However, in case of 3-(R)-hydroxypyrrolidine, the starting material, (R)-3-hydroxy-L-proline, is very expensive and thus is difficult to be applied to mass production.
[8] A method of obtaining (S)-3-hydroxypyrrolidine through several steps using D- malic acid as a raw material is known (Syn. Commun. 15, 587-598, 1985; J. Med. Chem. 1994, 37, 2138-2144). However, this technique has a disadvantage of multiple steps being involved and also has problems in that LiAlH4 or B2H6 used as a reduction agent is expensive and difficult to industrially handle. Further, since D-malic acid is expensive and is not mass-produced, this method is not an economical preparation method.
[9] Recently, a new synthetic method that comprises an epoxy ring-opening reaction by way of amine of 3,4-epoxy-l-butanol followed by 5-cyclization (WO2003/097594) has been reported. However, this method has a disadvantage in that raw materials are expensive. Further, synthesis of (S)-3-hydroxypyrrolidine and derivatives thereof through activation of a hydroxyl group followed by double substitution of amine, by using 1,2,4-trihydroxybutane, which is a derivative of 3,4-epoxy-l-butanol, as a starting material has been reported (WO2000/015610). However, this method also suffers from a problem that raw materials are expensive.
[10] As for similar methods, there has been known a synthetic method using a derivative of a 3,4-dihydroxy-l-butanol (JP60104061); a synthetic method using 3,4-dihydroxy-l-butylamine (JP57056457); and a synthetic method comprising cyan group substitution and cyan group reduction followed by cyclization, using 3-chloro-l,2-propandiol and derivatives thereof (EP431,521 and EP347,818). However, these preparation methods also have a problem in that it is difficult to industrially supply raw materials.
[11] Therefore, there is a need for development of a method of preparing
(S)-3-hydroxypyrrolidine using an inexpensive, optically active raw material as a starting material so that it can be industrially mass-produced.
Disclosure of Invention
Technical Problem
[12] The present invention is conceived to solve the aforementioned problems. It is an object of the present invention to provide a method of industrially and economically preparing (S)-3-hydroxypyrrolidine by using inexpensive, optically active 4-amino-(S)-2-hydroxybutylic acid as a starting material, and a method of optically or chemically purifying (S)-3-hydroxypyrrolidine through simple distillation under reduced pressure without an additional purification process. Technical Solution
[13] The present invention for achieving these objects has the following features.
[14] In one general aspect, a method of preparing (S)-3-hydroxypyrrolidine according to the present invention comprises the steps of: introducing an amine protecting group into an amine group of optically pure 4-amino-(S)-2-hydroxybutylic acid represented by the following Formula 2 used as a starting material; reducing a carboxylic acid group into a primary alcohol; removing the amine protecting group to form an amine salt; halogenating the primary alcohol to perform activation into a leaving group; and synthesizing optically pure (S)-3-hydroxypyrrolidine represented by the following Formula 1 through amine cyclization:
[15] <Formula 2> <Formula 1 >
[16]
[17] Further, a compound prepared in the step of forming the amine protecting group in the amine group of 4-amino-(S)-2-hydroxybutylic acid may comprise a compound represented by the following Formula 3:
[18] <Formula 3>
[19]
[20] where R is a C ~C linear or branched alkyl or benzyl group.
[21] Moreover, the step of reducing the carboxylic acid group to the primary alcohol may be performed by esterifying the carboxylic acid group into an ester compound represented by the following Formula 4 and reducing an ester group to the primary
alcohol:
[22] <Formula 4>
[23]
[24] where R is an amine protecting group, and R is a C ~C linear or branched alkyl or benzyl group. [25] Furthermore, a compound prepared in the step of removing the amine protecting group to form the amine salt may comprise a compound represented by the following
Formula 5: [26] [27] [28]
[29] <Formula 5>
[30]
HX
H2N
HOH
OH
[31] where HX is halogen acid or sulfuric acid.
[32] In addition, a compound prepared in the step of halogenating the primary alcohol to perform activation into the leaving group may comprise a compound represented by the following Formula 6: [33] <Formula 6>
[34]
HX
[35] where HX is halogen acid or sulfuric acid, and X is halogen.
[36] Further, the step of forming the amine protecting group in the amine group of
4-amino-(S)-2-hydroxybutylic acid may employ at least one reaction solvent selected from the group consisting of water, 1,4-dioxane, tetrahydrofuran and acetonitrile. [37] Moreover, the step of halogenating the primary alcohol to perform activation into the leaving group may use bromic acid and acetic acid, anhydride bromic acid or acetylbromide when the primary alcohol is brominated. [38] Furthermore, the step of halogenating the primary alcohol to perform activation into
a leaving group may be performed at a reaction temperature ranging from 0 to 1000C by using a C ~C liquid alkyl solvent with a carboxylic acid group as a reaction solvent.
[39] In addition, the step of synthesizing optically pure (S)-3-hydroxypyrrolidine through the amine cyclization may be performed by using water, C ~C linear or branched alcohol, or a mixture thereof as a reaction solvent, and Na CO , K CO , NaHCO , LiOH, NaOH, KOH, Ca(OH) or TEA as a base.
[40] In another general aspect, a method of preparing (S)-3-hydroxypyrrolidine according to the present invention comprises the steps of: forming an ester compound by esterifying a carboxylic acid group of optically pure 4-amino-(S)-2-hydroxybutylic acid represented by the following Formula 2 used as a starting material; forming a lactam compound through lactam cyclization of the ester compound; and synthesizing optically pure (S)-3-hydroxypyrrolidine represented by the following Formula 1 through amide reduction of the lactam compound:
[41] <Formula 2> <Formula 1>
[42]
[43] Further, the ester compound may comprise a compound represented by the following Formula 7: [44] <Formula 7>
[45]
[46] where R is a C ~C linear or branched alkyl or benzyl group, and HX is halogen acid or sulfuric acid.
[47] Moreover, the step of preparing the ester compound by esterifying the carboxylic acid group of optically pure 4-amino-(S)-2-hydroxybutylic acid may employ a base selected from the group consisting of sodium carbonate, potassium carbonate, sodium bicarbonate, potassium hydroxide, sodium hydroxide and a tertiary alcohol.
[48]
[49] *Furthermore, the step of synthesizing optically pure (S)-3-hydroxypyrrolidine through the amide reduction of the lactam compound may use diglym as a reaction solvent.
[50] In addition, the step of synthesizing optically pure (S)-3-hydroxypyrrolidine through the amide reduction of the lactam compound may be performed at a reaction temperature of 20 to 15O0C by using 1 to 10 equivalents of sodium borohydride as a reducing agent and 1 to 4 equivalents of sulfuric acid based on the lactam compound.
Advantageous Effects
[51] As described above, the present invention provides a method capable of economically and industrially preparing (S)-3-hydroxypyrrolidine by using inexpensive, optically active 4-amino-(S)-2-hydroxybutylic acid as a starting material, and preparing optically and chemically pure (S)-3-hydroxypyrrolidine through simple distillation under reduced pressure without an additional purification process. Best Mode for Carrying Out the Invention
[52] Hereinafter, the present invention will be described in greater detail.
[53]
[54] *The present invention provides a method of preparing optically and chemically pure (S)-3-hydroxypyrrolidine, which employs a process of the following Reaction Scheme 1 using 4-amino-(S)-2-hydroxybutylic acid as a starting material, or a mild reaction condition of Reaction Scheme 2 (to be described later) and a simple purifica tion process.
[55] First, the method of preparing (S)-3-hydroxypyrrolidine by using
4-amino-(S)-2-hydroxybutylic acid as a starting material according to the process of Reaction Scheme 1 will be described as follows:
[56] <Reaction Scheme 1>
[57]
2 3 5
S 7 η
[58] As shown in Reaction Scheme 1, the present invention provides a method of preparing (S)-3-hydroxypyrrolidine, which comprises the steps of: 1) introducing an amine protecting group into a compound 2 to obtain a compound 3; 2) reducing a carboxylic acid group of the compound 3 to a primary alcohol to obtain a compound 5; 3) removing the amine protecting group from the compound 5 to obtain an amine salt
6; 4) halogenating the primary alcohol of the amine salt 6 to obtain a compound 7 having an activated leaving group; and 5) performing amine cyclization of the compound 7 to obtain (S)-3-hydroxypyrrolidine 1.
[59] The step of introducing an amine protecting group into a compound 2 can be achieved by introducing an amine protecting group through amidation or carbamation conventionally used in the art. Specifically, the amine protecting group can be introduced in the form of amide by using C ~C aliphatic or aromatic alkylcarboxyl halide (or a leaving group such as an ester). Further, it is also possible to introduce the amine protecting group in the form of phthalimide by using phthalic anhydride. However, it is desirable to introduce the amine protecting group by using C ~C linear or branched alkyl or benzyl chloroformate (or chloride may be replaced by a leaving group such as halogen or alkoxy) to obtain the following compound 3 a:
[60]
3a
[61] where R is preferably a C ~C linear or branched alkyl or benzyl group.
[62] There is no limitation on a reaction solvent, but it is desirable to select the reaction solvent from the group consisting of water, 1,4-dioxane, tetrahydrofuran, acetonitrile and a mixture thereof.
[63] Sequentially, the step of preparing a compound 5 by reducing the carboxylic acid group of the compound 3 to a primary alcohol can be performed through a process of directly reducing a carboxylic acid group to a primary alcohol, which is known in the art, without any limitation. Reducing agents useful in the step include sodium borohydride (BH3)(JACS, 92, 1637, 1970; JOC 38, 2786, 1973), 9-BBN (JOC, 42, 512, 1977), sodium borohydride under the presence of a catalyst (JACS 78, 2582, 1956; Syn 695, 1980), lithium aluminum hydride (JACS, 109, 7816, 1987), and the like. Since details of the reduction methods can be found in these references, further description thereof will be omitted herein.
[64] As for a preferred reduction method enabling a higher yield and industrial mass production, the carboxylic acid group of the compound 3 is subjected to esterification to obtain the following ester compound, and the ester group of the compound 4 is then reduced to obtain the compound 5. The esterification may be performed by means of esterification of a carboxylic acid, which is known in the art, without any limitation.
[66] where it is preferred that R be an amine protecting group, and R be a C ~C linear or branched alkyl or benzyl group.
[67] The reduction of the ester compound 4 may be performed by means of reduction of an ester group into an alcohol, which is known in the art, without any limitation. Preferably, the reduction is carried out by using sodium borohydride as a reducing agent in an amount of 1 to 10 equivalents, more preferably 2 to 5 equivalents.
[68] Next, the step of preparing the amine salt 6 by removing the amine protecting group from the compound 5 can be achieved by removing the amine protecting group through agitation with or without reflux after addition of an acid such as halogen acid or sulfuric acid thereto. Sometimes, it is possible to form the amine salt 6 by removing the amine protecting group through addition of a base or hydrazine and adding a large quantity of acid thereto. It is most preferable to use bromic acid.
[69] Sequentially, in the step of preparing the compound 7 having an activated leaving group by halogenating the primary alcohol of the amine salt 6, the primary alcohol should be selectively halogenated. To this end, the selective activation of the primary alcohol in the present invention can be achieved by the halogenation.
[70] In case of performing the halogenation, all kinds of halogenating agents generally known in the art can be used, but it is preferable to perform bromination in view of reactivity by using, as a brominating agent, anhydride bromic acid, more preferably acetylbromide and bromic acid/acetic acid. In this case, an intermediate with an acetylated secondary alcohol is first synthesized, and a target substance with a brominated primary alcohol can be obtained by reacting the intermediate with an alcohol at an elevated temperature. It is preferable to employ a liquid compound having a C ~C alkylcarboxylic acid group as a reaction solvent, more preferably an acetic acid. This is carried out at a reaction temperature ranging from 0 to 1000C, preferably 10 to 5O0C for 1 to 24 hours, preferably for 3 to 6 hours.
[71] Next, the step of preparing (S)-3-hydroxypyrrolidine 1 through amine cyclization of the compound 7 uses a reaction solvent selected from the group consisting of water, a C ~C linear or branched alcohol and a mixture thereof, and a base selected from the group consisting of Na CO , K CO , NaHCO , LiOH, NaOH, KOH, Ca(OH) and TEA.
[72] After the reactions are completed, the resulting reaction mixture is concentrated
under reduced pressure to remove the solvent, and the concentrate thus obtained is then subjected to distillation under reduced pressure, thereby easily obtaining chemically and optically pure (S)-3-hydroxypyrrolidine 1.
[73] The amine cyclization may be carried out in succession to the step of preparing the compound 7 with an activated leaving group by halogenating the primary alcohol of the amine salt 6.
[74] The method of the following Reaction Scheme 2 as another method of the present invention is a method of preparing chemically and optically pure (S)-3-hydroxypyrrolidine under a mild reaction condition and through a simple purification process by using 4-amino-(S)-2-hydroxybutylic acid as a starting material.
[75] <Reaction Scheme 2>
[76]
OH OH
[77] where it is preferred that R be a C ~C linear or branched alkyl or benzyl group, and HX be halogen acid, sulfuric acid or fatty acid.
[78] As illustrated in Reaction Scheme 2, the present invention provides a method of preparing (S)-3-hydroxypyrrolidine 1, which comprises the steps of: 1) esterifying a carboxylic acid group of a starting material 2 to obtain an ester compound 8; 2) forming a lactam compound 9 through lactam cyclization of the ester compound 8; and 3) reducing a carbonyl group of the lactam compound 9 through amide reduction. The esterification and lactam cyclization mentioned above may be subjected to a purification process in each of the steps but are preferably performed consecutively without any purification process.
[79] In the step of preparing the ester compound 8 by esterifying the carboxylic acid group of the starting material 2, a C ~C linear or branched alkyl or benzyl alcohol is added to the starting material, an acidic condition is made by adding 1 to 10 equivalents, preferably 1 to 2 equivalents of halogen acid, sulfuric acid or an organic
acid, and then, the mixture is reacted at a temperature of 0 to 15O0C (or reflux condition) under the acidic condition. At this time, there is no limitation on a solvent, but it is preferable to employ a C ~C linear or branched alkyl or benzyl alcohol as a solvent.
[80] The step of forming the lactam compound 9 through lactam cyclization of the ester compound 8 may be subjected to an additional purification process after the step of preparing the ester compound 8 by esterifying the carboxylic acid group of the starting material 2. However, it is more desirable to consecutively perform these steps.
[81] There is no limitation on a base to be used, but it is preferable to employ sodium carbonate, potassium carbonate, sodium bicarbonate, potassium hydroxide, sodium hydroxide, or a linear or branched tertiary alkylamine with identical or different C ~C side chains. Further, the reaction solvent include, but is not limited to, water, an alcohol and the like, and it is preferable to use the same solvent as used for the preparation of the compound 8.
[82] Next, in the step of reducing the carbonyl group of the lactam compound 9 through amide reduction, it is preferable to use diglym as the reaction solvent and the reaction is performed by using 1 to 10 equivalents, preferably 2 to 5 equivalents of sodium borohydride and 2 to 4 equivalents of sulfuric acid at a reaction temperature of 20 to 15O0C, preferably 70 to 1000C. After the reaction is completed, the resulting reaction mixture is treated at pH 7 or more, concentrated under reduced pressure to remove the solvent, and then subjected to distillation under reduced pressure, thereby easily obtaining chemically and optically pure (S)-3-hydroxypyrrolidine 1.
[83] Hereinafter, the present invention will be described in greater detail in connection with examples. The following examples are given for the purpose of illustration and should not be constructed as limiting the scope of the invention. It will be apparent that other examples of the present invention can be easily conceived by those skilled in the art from the examples described herein and fall within the scope of the invention.
[84]
[85] Example 1: Preparation of 4-ethoxycarbonylamino-(S)-2-hydroxybutylic acid 3
[86] Distilled water (150D) and 4-amino-(S)-2-hydroxybutylic acid 2 (0.84 mol, 100 g), and sodium hydroxide (1.68 mol, 67 g) were added to a 1000 D round-bottom flask and completely dissolved. The mixture was cooled down below 50C. After a solution prepared by dissolving ethyl chloroformate (1.00 mol, 109 g) in 1,4-dioxane (100D) was gently dropped to the cooled mixture, the resulting mixture was agitated for 2 hours while maintaining reaction temperature at room temperature. The completion of the reaction was confirmed by TLC. The reaction mixture was concentrated under reduced pressure and cooled down to 1O0C, and then, its pH was lowered to 1.2 or less by adding concentrated hydrochloric acid. The resulting mixture was extracted with ethyl
acetate (450D), and the extract thus obtained was dried with anhydrous magnesium sulfate and then filtered and concentrated to obtain 153 g of 4-ethoxycarbonylamino-(S)-2-hydroxybutylic acid 3.
[87] 1H-NMR(D2O): δ 4.05-4.22 (m, IH), 3.83-3.95 (m, 2H), 3.15 (t, 2H, J = 10.5 Hz),
1.7-2.0 (m, 2H), 1.0-1.2 (m, 3H).
[88]
[89] Example 2: Preparation of 4-ethoxycarbonylamino-(S)-2-hydroxybutylic acid ethylester 4
[90] After 4-ethoxycarbonylamino-(S)-2-hydroxybutylic acid 3 (0.523 mol, 100 g) and
240D of anhydrous alcohol were added to a 500D round-bottom flask and completely dissolved, 5 g of concentrated sulfuric acid was gradually dropped thereto. The mixture was reacted under reflux for 10 hours. After the reaction was completed, the reaction mixture was cooled down to room temperature, neutralized with sodium bicarbonate, and then concentrated under reduced pressure to obtain 110 g of crude 4-ethoxycarbonylamino-(S)-2-hydroxybutylic acid ethylester 4.
[91] 1H-NMR (DMSO-d ): δ 4.03-4.2 (m, 3H), 3.9-4.0 (m, 2H), 3.03 (m, 2H), 1.2-2.0
(m, 2H), 1.0-1.2 (m, 6H).
[92]
[93] Example 3: Preparation of 4-ethyoxycarbonylamino-(S)-l,2-butandiol 5
[94] Sodium borohydride (1.00 mol, 37.8 g) and 200D of anhydrous ethanol were added to a IOOOD round-bottom flask, and reaction temperature was lowered to 50C. While carefully maintaining the reaction temperature below 150C, a solution prepared by dissolving 4-ethoxycarbonylamino-(S)-2-hydroxybutylic acid ethylester 4 (0.502 mol, 110 g) in 240D of anhydrous ethanol was gradually added to the mixture. The reaction mixture was agitated for 6 hours while maintaining the reaction temperature at 2O0C. After the completion of the reaction was confirmed, the reaction mixture was cooled down and kept below 50C. The reaction mixture was added with IOOD of methanol and agitated for 1 hour to inactivate sodium borohydride. Then, pH of the reaction mixture was adjusted to 1.2 or less by adding concentrated hydrochloric acid, and agitated at 50C for 1 hour. The final reaction mixture was filtered under reduced pressure to remove crystals generated during the reaction. A filtrate thus obtained was concentrated under reduced pressure to obtain 89 g of crude 4-ethoxycarbonylamino-(S)- 1 ,2-butandiol 5.
[95] 1H-NMR (D2O): δ 3.9-4.0 (m, 2H), 3.6-3.65 (m, IH), 3.43-3.5 (m, IH), 3.3-3.4 (1,
IH), 3.0-3.08 (m, 2H), 1.4-1.5 (m, 2H), 1.08 (t, 3H, J = 6.9 Hz).
[96]
[97] Example 4: Preparation of 4-amino-(S)-l,2-butandiol bromate 6
[98] After 4-ethoxycarbonylamino-(S)- 1 ,2-butandiol 5 (0.564 mol, 100 g) and 48% HBr
(285 g) were added to a 500D round-bottom flask and completely dissolved, the reaction mixture was agitated under reflux for 5 hours. After the completion of the reaction was confirmed, the resulting mixture was concentrated under reduced pressure to obtain 109 g of crude 4-amino-(S)-l,2-butandiol bromate 6.
[99] 1H-NMR (D O): δ 3.62-3.68 (m, IH), 3.3-3.5 (m, 2H), 2.9-3.1 (m, 2H), 1.5-1.8 (m,
2H).
[100]
[101] Example 5: Preparation of 4-amino-l-bromo-(S)-2-butanol bromate 7
[102] 4-Amino-(S)-l,2-butandiol bromate 6 (0.537 mol, 100 g) and an acetic acid solution
(185 g) with 33% bromic acid dissolved therein were added to a 500D round-bottom flask and the mixture was agitated at 4O0C for 2 hours. After the preparation of an intermediate was confirmed by Thin Layer Chromatography (TLC), anhydrous ethanol (285 g) was added thereto. The reaction mixture was agitated under reflux for 3 hours to complete the reaction and then concentrated under reduced pressure to completely remove the solvent, thereby obtaining 115 g of crude 4-amino-l-bromo-(S)-2-butanol bromate 7.
[103] 1H-NMR (D2O): δ 3.97-4.02 (m, IH), 3.45-3.51 (m, 2H), 3.43-3.5 (m, IH), 3.15 (t,
2H, J = 7.2 Hz), 1.86-2.01 (m, 2H).
[104]
[105] Example 6: Preparation of (S)-3-hydroxypyrrolidine 1
[106] After 4-amino-l-bromo-(S)-2-butanol bromate 7 (2.001 mol, 500 g) and ethanol
(1500D) were added to a 3000D round-bottom flask and completely dissolved, potassium carbonate (555 g) was added thereto and the mixture was agitated under reflux for 4 hours to complete the reaction. After the completion of the reaction was confirmed, the reaction mixture was cooled down to room temperature, added with potassium hydroxide (250 g), and agitated again under reflux for 2 hours. After the reaction mixture solution was cooled down to room temperature, it was filtered under reduced pressure to remove generated salts. A filtrate thus obtained was concentrated under reduced pressure to obtain 170 g of crude (S)-3-hydroxypyrrolidine. The obtained compound was distillated under reduced pressure at conditions of 3 mmHg and 120oC to obtain 127 g of pure (S)-3-hydroxypyrrolidine 1.
[107] 1H-NMR (CDCl ): δ 4.3-4.4 (m, IH), 3.05-3.15 (m, IH), 3.0 (bs, 2H), 2.75-2.9 (m,
3H), 1.85-2.0 (m, IH), 1.6-1.75 (m, IH).
[108]
[109] Example 7: Preparation of (S)-3-hydroxypyrrolidine 1
[110] (S)-3-Hydroxypyrrolidine 1 could be prepared even when performing the reaction by using the same raw materials as Example 6 but adding 100 g of potassium hydroxide as a base.
[111]
[112] *
[113] Example 8: Preparation of (S)-3-hydroxy-2-pyrrolidineon 9
[114] After 4-amino-(S)-2-hydroxybutylic acid 2 (0.1 mol, 11.91 g) was dissolved in a solvent of methanol (1.5mol, 48.06g) contained in a 500D round-bottom flask, sulfuric acid (1 to 2 equivalents) was added thereto at 250C. When
4-amino-(S)-2-hydroxybutylic acid 2 was completely dissolved, the reaction mixture was heated to 8O0C and agitated under reflux for 4 hours to complete the reaction. Thereafter, 4-amino-(S)-2-hydroxybutylic acid methylester sulfonate 8 was confirmed by NMR.
[115] 1H-NMR (D O): δ 4.46 (dd, IH, J = 8.4 Hz, 4.2Hz), 3.78 (s, 3H), 3.17 (t, 2H, J =
7.2Hz), 2.18-2.35 (m, IH), 1.95-2.13 (m, IH).
[116]
[117] After the reaction mixture was cooled down to room temperature, water (11.91 g) and potassium carbonate were added thereto and agitated at room temperature for 12 hours to obtain (S)-3-hydroxy-2-pyrrolidineon. At this time, the formation of (S)-3-hydroxy-2-pyrrolidineon was confirmed by NMR. Inorganic substances, which were precipitated by adding methanol to a residue obtained after filtering and concentrating the reaction mixture, were removed by filtering the reaction mixture twice, and a filtrate thus obtained was concentrated under reduced pressure to obtain (S)-3-hydroxy-2-pyrrolidineon 9 (yield: 89%).
[118] 1H-NMR (DMSO-d ): δ 7.6 (bs, IH), 5.4 (bs, IH), 3.97 (t, IH, J = 8.4 Hz), 3.0-3.2
(m, 2H), 2.2-2.3 (m, IH), 1.6-1.8 (m, IH).
[119]
[120] Example 9: Preparation of (S)-3-hydroxypyrrolidine 1
[121] (S)-3-Hydroxy-2-pyrrolidineon 9 (0.1 mol, 10.11 g), diglym (1.13 mol, 151.65 g) and NaBH (0.4 mol, 15.13 g) were added to a 500D round-bottom flask at 25oC°C, and sulfuric acid (20.2 g) was gently dropped thereto for 1 hour. After the dropping, the mixture was heated to 8O0C and kept for 12 hours to complete the reaction. When the reaction was completed, methanol was added thereto to inactivate the reaction, and the reaction mixture was neutralized with diluted hydrochloric acid (0.4 mol, 41.67 g). Then, pH of the reaction mixture was adjusted to 11 or more by using an aqueous sol ution of sodium hydroxide (ION 35D), and salts precipitated therefrom were removed through filtration. A resulting filtrate was concentrated under reduced pressure to obtain a (S)-3-hydroxypyrrolidine 1 residue. The residue was distilled under reduced pressure to obtain pure (S)-3-hydroxypyrrolidine 1.
[122] 1H-NMR (CDCl ): δ 4.3-4.4 (m, IH), 3.05-3.15 (m, IH), 3.0 (bs, 2H), 2.75-2.9 (m,
3H), 1.85-2.0 (m, IH), 1.6-1.75 (m, IH).
[123] [124]
Industrial Applicability
[125] As described above, the present invention provides a method of economically and industrially preparing (S)-3-hydroxypyrrolidine, and preparing optically and chemically pure (S)-3-hydroxypyrrolidine through simple distillation under reduced pressure without an additional purification process during reaction. (S)-3-hydroxypyrrolidine thus prepared can be effectively used as a major raw material for preparation of various chiral pharmaceutical products, such as a major intermediate raw material of a calcium antagonist (Barnidipine), carbapenem antibiotics, quinolone- based antibiotics, analgesics, and a major intermediate raw material of a neurotransmitter, in a very wide industrial field.
[126]
[127]
Claims
[1] A method of preparing (S)-3-hydroxypyrrolidine, comprising the steps of: forming an amine protecting group in an amine group by using optically pure
4-amino-(S)-2-hydroxybutylic acid represented by the following Formula 2 as a starting material; reducing a carboxylic acid group to a primary alcohol; removing the amine protecting group to form an amine salt; halogenating the primary alcohol to perform activation into a leaving group; and synthesizing optically pure (S)-3-hydroxypyrrolidine represented by the following Formula 1 through amine cyclization:
<Formula 2> <Formula 1>
[2] The method as claimed in claim 1, wherein a compound prepared in the step of forming the amine protecting group in the amine group of 4-amino-(S)-2-hydroxybutylic acid comprises a compound represented by the following Formula 3: <Formula 3>
[3] The method as claimed in claim 1, wherein the step of reducing the carboxylic acid group into the primary alcohol is performed by esterifying the carboxylic acid group into an ester compound represented by the following Formula 4 and reducing an ester group into the primary alcohol: <Formula 4>
[4] The method as claimed in claim 1, wherein a compound prepared in the step of
removing the amine protecting group to form the amine salt comprises a compound represented by the following Formula 5: <Formula 5>
HX
H2N
HOH
OH where HX is halogen acid or sulfuric acid.
[5] The method as claimed in claim 1, wherein a compound prepared in the step of halogenating the primary alcohol to perform activation into the leaving group comprises a compound represented by the following Formula 6: <Formula 6>
HX
[6] The method as claimed in claim 1, wherein the step of forming the amine protecting group in the amine group of 4-amino-(S)-2-hydroxybutylic acid employs at least one reaction solvent selected from the group consisting of water, 1,4-dioxane, tetrahydrofuran and acetonitrile.
[7] The method as claimed in claim 1, wherein the step of halogenating the primary alcohol to perform activation into the leaving group uses bromic acid and acetic acid, anhydride bromic acid or acetylbromide when the primary alcohol is brominated.
[8] The method as claimed in claim 1, wherein the step of halogenating the primary alcohol to perform activation into a leaving group is performed at a reaction temperature ranging from 0 to 1000C by using a C ~C liquid alkyl solvent with a
1 4 carboxylic acid group as a reaction solvent.
[9] The method as claimed in claim 1, wherein the step of synthesizing optically pure (S)-3-hydroxypyrrolidine through the amine cyclization is performed by using water, C ~C linear or branched alcohol, or a mixture thereof as a reaction
1 4 solvent, and Na CO , K CO , NaHCO , LiOH, NaOH, KOH, Ca(OH) or TEA as
2 3 2 3 3 2 a base.
[10] A method of preparing (S)-3-hydroxypyrrolidine, comprising the steps of: forming an ester compound by esterifying a carboxylic acid group of optically pure 4-amino-(S)-2-hydroxybutylic acid represented by the following Formula 2 used as a starting material; forming a lactam compound through lactam cyclization of the ester compound;
and synthesizing optically pure (S)-3-hydroxypyrrolidine represented by the following Formula 1 through amide reduction of the lactam compound: <Formula 2> <Formula 1>
[11] The method as claimed in claim 10, wherein the ester compound comprises a compound represented by the following Formula 7: <Formula 7>
[12] The method as claimed in claim 10, wherein the step of preparing the ester compound by esterifying the carboxylic acid group of optically pure 4-amino-(S)-2-hydroxybutylic acid employs a base selected from the group consisting of sodium carbonate, potassium carbonate, sodium bicarbonate, potassium hydroxide, sodium hydroxide and a tertiary alcohol.
[13] The method as claimed in claim 10, wherein the step of synthesizing optically pure (S)-3-hydroxypyrrolidine through the amide reduction of the lactam compound uses diglym as a reaction solvent.
[14] The method as claimed in claim 13, wherein the step of synthesizing optically pure (S)-3-hydroxypyrrolidine through the amide reduction of the lactam compound is performed at a reaction temperature of 20 to 15O0C by using 1 to 10 equivalents of sodium borohydride as a reducing agent and 1 to 4 equivalents of sulfuric acid based on the lactam compound.
[15] The method as claimed in claim 10, wherein the step of forming the ester compound by esterifying the carboxylic acid group of optically pure 4-amino-(S)-2-hydroxybutylic acid and the step of synthesizing optically pure (S)-3-hydroxypyrrolidine through the amide reduction of the lactam compound are performed in a consecutive manner.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/996,011 US7652152B2 (en) | 2005-07-20 | 2006-07-19 | Synthetic method of optically pure (S)-3-hydroxypyrrolidine |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050065698A KR100939347B1 (en) | 2005-07-20 | 2005-07-20 | Synthetic Method of optically pure S-3-hydroxypyrrolidine |
KR10-2005-0065698 | 2005-07-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007011162A1 true WO2007011162A1 (en) | 2007-01-25 |
Family
ID=37669012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2006/002835 WO2007011162A1 (en) | 2005-07-20 | 2006-07-19 | Synthetic method of optically pure (s)-3-hydroxypyrrolidine |
Country Status (3)
Country | Link |
---|---|
US (1) | US7652152B2 (en) |
KR (1) | KR100939347B1 (en) |
WO (1) | WO2007011162A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010013427A (en) * | 2008-06-30 | 2010-01-21 | Chiroad Inc | Method for producing optically pure (s)-3-hydroxypyrrolidine |
US7893062B2 (en) | 2007-04-20 | 2011-02-22 | Hoffmann-La Roche Inc. | Pyrrolidine derivatives as dual NK1/NK3 receptor antagonists |
US8012998B2 (en) | 2007-08-07 | 2011-09-06 | Hoffmann—La Roche Inc. | Pyrrolidine aryl-ether as NK-3 receptor antagonists |
WO2012121361A1 (en) | 2011-03-10 | 2012-09-13 | 第一三共株式会社 | Dispiropyrrolidine derivative |
EP4382529A1 (en) | 2022-12-07 | 2024-06-12 | Bayer Consumer Care AG | A process for preparing pure (3s)-pyrrolidin-3-ol and pure (3s)-pyrrolidin-3-ol hydrochloride |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997040008A1 (en) * | 1996-04-22 | 1997-10-30 | Kaneka Corporation | Process for preparing pyrrolidine derivatives |
WO1997043256A1 (en) * | 1996-05-14 | 1997-11-20 | Kyowa Hakko Kogyo Co., Ltd. | Process for the preparation of 3-hydroxypyrrolidine |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5756457A (en) | 1980-08-14 | 1982-04-05 | Koei Chem Co Ltd | Preparation of 3-pyrrolidinol |
JPS60104061A (en) | 1983-11-08 | 1985-06-08 | Sankyo Co Ltd | Preparation of pyrrolidine derivative |
GR850872B (en) | 1984-04-16 | 1985-11-25 | Yamanouchi Pharma Co Ltd | |
JPS6163652A (en) | 1984-09-04 | 1986-04-01 | Yamanouchi Pharmaceut Co Ltd | Preparation of (s)-(-)-1-benzyl-3-hydroxypyrrolidine |
FI83517C (en) | 1985-01-24 | 1991-07-25 | Yamanouchi Pharma Co Ltd | Process for Preparation of Right-Twisting Optical Isomer of (+ -) - 2,6-Dimethyl-4- (m-nitrophenyl) -1,4-dihydropyridin-3,5-dicarboxylic acid 3- (1-benzylpyrrolidin-3-yl) ester-5-methyl ester (YM-09730) of A-diastereomer |
WO1988008845A1 (en) | 1987-05-11 | 1988-11-17 | Pfizer Inc. | Diastereomeric 5r,6s-6-(1r-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids |
US4851418A (en) | 1987-08-21 | 1989-07-25 | Warner-Lambert Company | Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent |
IE62338B1 (en) * | 1988-06-22 | 1995-01-25 | Kanegafuchi Chemical Ind | Process for preparing 3-pyrrolidinol |
DE68905247T2 (en) | 1988-06-23 | 1993-10-07 | Celotex Corp | Mineral fiber acoustic panel and process for its manufacture. |
GB8824400D0 (en) | 1988-10-18 | 1988-11-23 | Glaxo Group Ltd | Chemical compounds |
US4916141A (en) | 1989-03-28 | 1990-04-10 | Warner-Lambert Company | (S)-7-(3-amino-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid |
DE3910920A1 (en) | 1989-04-05 | 1990-10-11 | Bayer Ag | ENANTIOMERIC PURE 7- (3-AMINO-1-PYRROLIDINYL) QUINOLON AND NAPHTHYRIDONE CARBONIC ACIDS |
EP0398726A1 (en) | 1989-05-19 | 1990-11-22 | S.S.A. PACKAGING ENGINEERING & CONSULTANT PTY. LTD. | Method and apparatus for packing flexible packages |
JP2735326B2 (en) | 1989-12-02 | 1998-04-02 | 鐘淵化学工業株式会社 | Method for producing 3-pyrrolidinol |
JPH05255204A (en) | 1992-03-11 | 1993-10-05 | Kanegafuchi Chem Ind Co Ltd | Production of amines |
KR100295740B1 (en) | 1998-09-17 | 2001-11-05 | 박영구 | Method for preparing N-substituted-hydroxycyclic alkylamine derivatives |
WO2001019817A2 (en) | 1999-09-14 | 2001-03-22 | Abbott Laboratories | 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission |
JP4665185B2 (en) | 2000-02-09 | 2011-04-06 | 東レ・ファインケミカル株式会社 | Production method of amines |
KR100461569B1 (en) | 2002-05-20 | 2004-12-14 | 삼성정밀화학 주식회사 | Process for producing optically pure 3-hydroxy-pyrrolidine |
-
2005
- 2005-07-20 KR KR1020050065698A patent/KR100939347B1/en not_active IP Right Cessation
-
2006
- 2006-07-19 US US11/996,011 patent/US7652152B2/en not_active Expired - Fee Related
- 2006-07-19 WO PCT/KR2006/002835 patent/WO2007011162A1/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997040008A1 (en) * | 1996-04-22 | 1997-10-30 | Kaneka Corporation | Process for preparing pyrrolidine derivatives |
WO1997043256A1 (en) * | 1996-05-14 | 1997-11-20 | Kyowa Hakko Kogyo Co., Ltd. | Process for the preparation of 3-hydroxypyrrolidine |
Non-Patent Citations (1)
Title |
---|
HARRIS B.D. ET AL.: "Synthesis of 3S-pyrrolidinol from L-glutamic acid", SYNTHETIC COMMUNICATIONS, vol. 16, no. 14, 1986, pages 1815 - 1822, XP008075594 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7893062B2 (en) | 2007-04-20 | 2011-02-22 | Hoffmann-La Roche Inc. | Pyrrolidine derivatives as dual NK1/NK3 receptor antagonists |
US8012998B2 (en) | 2007-08-07 | 2011-09-06 | Hoffmann—La Roche Inc. | Pyrrolidine aryl-ether as NK-3 receptor antagonists |
JP2010013427A (en) * | 2008-06-30 | 2010-01-21 | Chiroad Inc | Method for producing optically pure (s)-3-hydroxypyrrolidine |
WO2012121361A1 (en) | 2011-03-10 | 2012-09-13 | 第一三共株式会社 | Dispiropyrrolidine derivative |
EP4382529A1 (en) | 2022-12-07 | 2024-06-12 | Bayer Consumer Care AG | A process for preparing pure (3s)-pyrrolidin-3-ol and pure (3s)-pyrrolidin-3-ol hydrochloride |
WO2024121219A1 (en) | 2022-12-07 | 2024-06-13 | Bayer Consumer Care Ag | A process for preparing pure (3s)-pyrrolidin-3-ol and pure (3s)-pyrrolidin-3-ol hydrochloride |
Also Published As
Publication number | Publication date |
---|---|
US7652152B2 (en) | 2010-01-26 |
KR20070010794A (en) | 2007-01-24 |
KR100939347B1 (en) | 2010-01-29 |
US20080214837A1 (en) | 2008-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5632279B2 (en) | Preparation method and polymorph of ivabradine hydrochloride | |
KR101609898B1 (en) | A process for preparing r-beta-amino phenylbutyric acid derivatives | |
JPH07309834A (en) | Production of diarylprolinol enantiomerically pure | |
TW200808770A (en) | Novel processes for the preparation of DPP IV inhibitors | |
WO2013020460A1 (en) | Atazanavir preparation method | |
WO2007011162A1 (en) | Synthetic method of optically pure (s)-3-hydroxypyrrolidine | |
US9771317B2 (en) | Process for preparing lacosamide and related compounds | |
JP5899204B2 (en) | Process for producing chiral β-aminocarboxamide derivative | |
CN105358529B (en) | A kind of new method of synthesis Eliquis important intermediate | |
CN106008316B (en) | A kind of method of synthesis Lei Dipawei chiral intermediates | |
HU229189B1 (en) | Process for the preparation of n-[(s)-1-carboxy-butyl]-(s)-alanine esters and their use for synthesizing perindopril | |
WO2006092809A1 (en) | PROCESS FOR PRODUCING POLYMORPH FORM (I) OF l-BENZYL-4- [(5, 6-DIMETHOXY-l-INDANONE) -2YL] METHYL PIPERIDINE HYDROCHLORIDE (DONEPEZIL HYDROCHLORIDE) | |
AU2003248428B2 (en) | Process for the preparation of enantiomerically pure N-methyl-N-[(1S)-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamide | |
JP2001261644A (en) | Hexahydroisoindoline acid-addition salt and method for applying the same | |
WO2008096373A2 (en) | Process for synthesizing highly pure nateglinide polymorphs | |
TW200403222A (en) | Process for the preparation of amino-pyrrolidine derivatives | |
WO2015109377A1 (en) | Process for preparing donepezil hydrochloride forms i and iii; and an intermediate compound thereof | |
JPH08169878A (en) | Production of optically active pyrrolidine having high enantiomer purity | |
CA2569686A1 (en) | Highly selective novel amidation method | |
RU2741389C1 (en) | Method for preparing intermediate compound for synthesis of medicinal agent | |
JP4855446B2 (en) | Process for the production of optically pure (S) -3-hydroxypyrrolidine | |
WO2005000810A1 (en) | Process for producing nitrogenous heterocyclic compound | |
WO2005066124A1 (en) | Method for producing pyrrolidine derivative | |
KR100336400B1 (en) | A Process for Preparing Cisapride | |
JPH0434967B2 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 11996011 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06783350 Country of ref document: EP Kind code of ref document: A1 |